Skip to main content
. 2024 Oct 23;15(11):1843–1851. doi: 10.1021/acsmedchemlett.4c00269

Figure 4.

Figure 4

Kaplan–Meier survival analysis of NSGS mice engrafted with MOLM14 (ITD, D835Y) cells and dosed with 10 mg/kg IP compound 31 or Gilteritinib.